6z1k
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==A de novo Enzyme for the Morita-Baylis-Hillman Reaction BH32.6== | ==A de novo Enzyme for the Morita-Baylis-Hillman Reaction BH32.6== | ||
- | <StructureSection load='6z1k' size='340' side='right'caption='[[6z1k]]' scene=''> | + | <StructureSection load='6z1k' size='340' side='right'caption='[[6z1k]], [[Resolution|resolution]] 1.48Å' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6Z1K OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6Z1K FirstGlance]. <br> | + | <table><tr><td colspan='2'>[[6z1k]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Synthetic_construct_sequences Synthetic construct sequences]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=6Z1K OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=6Z1K FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6z1k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6z1k OCA], [https://pdbe.org/6z1k PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6z1k RCSB], [https://www.ebi.ac.uk/pdbsum/6z1k PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6z1k ProSAT]</span></td></tr> | + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=CA:CALCIUM+ION'>CA</scene>, <scene name='pdbligand=EDO:1,2-ETHANEDIOL'>EDO</scene>, <scene name='pdbligand=FMT:FORMIC+ACID'>FMT</scene>, <scene name='pdbligand=PEG:DI(HYDROXYETHYL)ETHER'>PEG</scene></td></tr> |
+ | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=6z1k FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=6z1k OCA], [https://pdbe.org/6z1k PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=6z1k RCSB], [https://www.ebi.ac.uk/pdbsum/6z1k PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=6z1k ProSAT]</span></td></tr> | ||
</table> | </table> | ||
+ | <div style="background-color:#fffaf0;"> | ||
+ | == Publication Abstract from PubMed == | ||
+ | The combination of computational design and directed evolution could offer a general strategy to create enzymes with new functions. So far, this approach has delivered enzymes for a handful of model reactions. Here we show that new catalytic mechanisms can be engineered into proteins to accelerate more challenging chemical transformations. Evolutionary optimization of a primitive design afforded an efficient and enantioselective enzyme (BH32.14) for the Morita-Baylis-Hillman (MBH) reaction. BH32.14 is suitable for preparative-scale transformations, accepts a broad range of aldehyde and enone coupling partners and is able to promote selective monofunctionalizations of dialdehydes. Crystallographic, biochemical and computational studies reveal that BH32.14 operates via a sophisticated catalytic mechanism comprising a His23 nucleophile paired with a judiciously positioned Arg124. This catalytic arginine shuttles between conformational states to stabilize multiple oxyanion intermediates and serves as a genetically encoded surrogate of privileged bidentate hydrogen-bonding catalysts (for example, thioureas). This study demonstrates that elaborate catalytic devices can be built from scratch to promote demanding multi-step processes not observed in nature. | ||
+ | |||
+ | Engineering an efficient and enantioselective enzyme for the Morita-Baylis-Hillman reaction.,Crawshaw R, Crossley AE, Johannissen L, Burke AJ, Hay S, Levy C, Baker D, Lovelock SL, Green AP Nat Chem. 2021 Dec 16. pii: 10.1038/s41557-021-00833-9. doi:, 10.1038/s41557-021-00833-9. PMID:34916595<ref>PMID:34916595</ref> | ||
+ | |||
+ | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | ||
+ | </div> | ||
+ | <div class="pdbe-citations 6z1k" style="background-color:#fffaf0;"></div> | ||
+ | == References == | ||
+ | <references/> | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: Levy | + | [[Category: Synthetic construct sequences]] |
+ | [[Category: Levy, C W]] | ||
+ | [[Category: Biosynthetic protein]] | ||
+ | [[Category: Engineered]] | ||
+ | [[Category: Evolved]] | ||
+ | [[Category: Morita-baylis-hillman reaction]] |
Revision as of 07:08, 2 February 2022
A de novo Enzyme for the Morita-Baylis-Hillman Reaction BH32.6
|